The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study

The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study

Background and aimsThe roles of sodium-glucose cotransporter 2 inhibitor (SGLT2i) in acute heart failure (AHF) risk after acute myocardial infarction (AMI) remain unclear. In this study, we explored the correlation between SGLT2i administration and short-term in-hospital AHF risk in AMI patients.Met...

Full description

Bibliographic Details
Main Authors: Yi Zhu, Jia-li Zhang, Hong Jin, Yuan Ji, Fang-fang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
SGLT2I
AHF
AMI
NSTEMI
hospitalization
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1158507/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1158507/full

Similar Items